Sequential Screening for Heterozygous Familial Hypercholesterolemia Not Cost-Effective

WEDNESDAY, Nov. 19, 2025-- Sequential screening for heterozygous familial hypercholesterolemia (FH) in childhood or early adulthood can be effective but is not cost-effective compared with usual care, according to a study published online Nov. 9...